Immunome Inc.
Ticker: 1472012
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 | Q2 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 4.02+37.2% | 2.93+0.7% | 2.91+0.0% | 2.91+23.3% | 2.36+129.1% | 1.03-71.1% | 3.57-16.2% | 4.26 |
| Total Income | 4.02+37.2% | 2.93+0.7% | 2.91+0.0% | 2.91+23.3% | 2.36+129.1% | 1.03-71.1% | 3.57-16.2% | 4.26 |
| EXPENSES | ||||||||
| Expenditure | 50.49+6.2% | 47.56-11.0% | 53.43+0.0% | 53.43+26.1% | 42.37-68.2% | 133.33+1526.0% | 8.20-18.3% | 10.04 |
| PROFIT | ||||||||
| Net Profit | -43.40-4.2% | -41.64+11.6% | -47.10+0.0% | -47.10-30.4% | -36.12+72.1% | -129.49-2876.8% | -4.35+21.8% | -5.56 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.50+3.8% | -0.52+33.3% | -0.78+0.0% | -0.78-30.0% | -0.60+76.1% | -2.51-597.2% | -0.36+21.7% | -0.46 |
Corporate Events
Board MeetingIMNM
20269Jun
Board Meeting
Immunome Inc. held its 2026 Annual Meeting of Stockholders t…
SEC Filing ↗